Novartis Pharmaceuticals Corporation et al v. Roxane Laboratories Inc.
| Novartis Pharmaceuticals Corporation and Novartis AG |
| Roxane Laboratories Inc. |
| 1:2015cv00474 |
| June 10, 2015 |
| US District Court for the District of Delaware |
| Wilmington Office |
| XX US, Outside State |
| Richard G. Andrews |
| Patent |
| 35 U.S.C. ยง 271 |
| None |
Follow case documents by RSS
Available Case Documents
The following documents for this case are available for you to view or download:
| Document Text |
|---|
Filing
100
TRIAL OPINION: Defendant failed to prove by clear and convincing evidence that the asserted claims of the '131 and '224 patents are invalid as obvious. Signed by Judge Richard G. Andrews on 12/14/2017. (nms)
|
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
